NCT00700323View on ClinicalTrials.gov

PS-Omega3 Supplementation to Attention Deficit Hyperactivity Disorder (ADHD) Children

PHASE2UnknownINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions
ADHD
Interventions
DIETARY_SUPPLEMENT

PS-Omega3 conjugate supplementation

DIETARY_SUPPLEMENT

placebo

Trial Locations (1)

Unknown

Tel-Aviv Sourasky Medical Center, Tel Aviv

Sponsors

Collaborators (1)

Enzymotec
All Listed Sponsors
collaborator

Enzymotec

INDUSTRY

lead

Tel-Aviv Sourasky Medical Center

OTHER_GOV